400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Epigenetics / HDAC / Pyroxamide
CAS No.: 382180-17-8
Pyroxamide is an inhibitor of histone deacetylase (HDAC) which potently inhibits affinity purified HDAC1. Also inhibits the growth of tumor cells in vitro and in vivo. Induces p21/WAF1 expression in tumor cells.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00042900 | Chronic Myeloproliferative Dis... more >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse << |
实验方案
技术信息
CAS号 | 382180-17-8 | 储存条件 |
|
|
分子式 | C13H19N3O3 | 运输 | 蓝冰 | |
分子量 | 265.31 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00042900 | Chronic Myeloproliferative Dis... more >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网